Loading…
Experience with the ketogenic diet in premature neonates
The ketogenic diet is a time‐tested, potent, nonpharmacological treatment of epilepsy. However, the use of the ketogenic diet in premature neonates with epilepsy has not been previously reported. We share our experience with the use of ketogenic diet therapy in two premature neonates. Two identical...
Saved in:
Published in: | Epilepsia open 2023-03, Vol.8 (1), p.200-204 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c5813-b991cda40f3ad1a48c9461c6251881564e39b81ef1c7e56e67daab008c6bb8ae3 |
---|---|
cites | cdi_FETCH-LOGICAL-c5813-b991cda40f3ad1a48c9461c6251881564e39b81ef1c7e56e67daab008c6bb8ae3 |
container_end_page | 204 |
container_issue | 1 |
container_start_page | 200 |
container_title | Epilepsia open |
container_volume | 8 |
creator | Phitsanuwong, Chalongchai Kim, Jeong‐A Schimpf, Stephanie Nordli, Douglas R. |
description | The ketogenic diet is a time‐tested, potent, nonpharmacological treatment of epilepsy. However, the use of the ketogenic diet in premature neonates with epilepsy has not been previously reported. We share our experience with the use of ketogenic diet therapy in two premature neonates. Two identical twin premature neonates with SCN2A‐related developmental and epileptic encephalopathy, whose seizures were refractory to multiple anti‐seizure medications, were started on the classic ketogenic diet at the conceptual age of 35 weeks. Ketosis was achieved and maintained (range 2‐5 mmol/L of serum beta‐hydroxybutyrate level). Seizure frequency was significantly reduced (>90% reduction in both patients), and some anti‐seizure medications were able to be discontinued. Initial transient weight loss and one episode of asymptomatic hypoglycemia were observed and corrected. The ketogenic diet was found to be a safe, well‐tolerated, and effective treatment for seizures in two premature neonates. The side effects are tolerable and correctable. The ketogenic diet, therefore, is a treatment option for refractory seizures in this age group, when administered under expert guidance. |
doi_str_mv | 10.1002/epi4.12673 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_9ec67ddf4bea497abb1b62515a7c8e1d</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_9ec67ddf4bea497abb1b62515a7c8e1d</doaj_id><sourcerecordid>2781016420</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5813-b991cda40f3ad1a48c9461c6251881564e39b81ef1c7e56e67daab008c6bb8ae3</originalsourceid><addsrcrecordid>eNp9kU1v1DAQhi0EolXphR-AInFBSFs8seOPCxKqFlipEhzgbNnOZNdLNg6OQ-m_x9uUquXAyZbn8TOjeQl5CfQCKK3f4Rj4BdRCsifktOaSrnTN9NMH9xNyPk17SinoGkDQ5-SECaYVl80pUevfI6aAg8fqOuRdlXdY_cActzgEX7UBcxWGakx4sHlOWA0YB5txekGedbaf8PzuPCPfP66_XX5eXX35tLn8cLXyjQK2clqDby2nHbMtWK685gK8qBtQChrBkWmnADvwEhuBQrbWOkqVF84pi-yMbBZvG-3ejCkcbLox0QZz-xDT1tiUg-_RaPTle9txh5ZraZ0Dd2zUWOkVQltc7xfXOLsDth6HnGz_SPq4MoSd2cZfRmspJVdF8OZOkOLPGadsDmHy2Pe2rGWeTC2ZAs2VpAV9_Q-6j3MayqoKpYCC4PWRertQPsVpStjdDwPUHPM1x3zNbb4FfvVw_Hv0b5oFgAW4Dj3e_Edl1l83fJH-AYWTr4s</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2781016420</pqid></control><display><type>article</type><title>Experience with the ketogenic diet in premature neonates</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><source>Wiley Open Access</source><creator>Phitsanuwong, Chalongchai ; Kim, Jeong‐A ; Schimpf, Stephanie ; Nordli, Douglas R.</creator><creatorcontrib>Phitsanuwong, Chalongchai ; Kim, Jeong‐A ; Schimpf, Stephanie ; Nordli, Douglas R.</creatorcontrib><description>The ketogenic diet is a time‐tested, potent, nonpharmacological treatment of epilepsy. However, the use of the ketogenic diet in premature neonates with epilepsy has not been previously reported. We share our experience with the use of ketogenic diet therapy in two premature neonates. Two identical twin premature neonates with SCN2A‐related developmental and epileptic encephalopathy, whose seizures were refractory to multiple anti‐seizure medications, were started on the classic ketogenic diet at the conceptual age of 35 weeks. Ketosis was achieved and maintained (range 2‐5 mmol/L of serum beta‐hydroxybutyrate level). Seizure frequency was significantly reduced (>90% reduction in both patients), and some anti‐seizure medications were able to be discontinued. Initial transient weight loss and one episode of asymptomatic hypoglycemia were observed and corrected. The ketogenic diet was found to be a safe, well‐tolerated, and effective treatment for seizures in two premature neonates. The side effects are tolerable and correctable. The ketogenic diet, therefore, is a treatment option for refractory seizures in this age group, when administered under expert guidance.</description><identifier>ISSN: 2470-9239</identifier><identifier>EISSN: 2470-9239</identifier><identifier>DOI: 10.1002/epi4.12673</identifier><identifier>PMID: 36398475</identifier><language>eng</language><publisher>United States: John Wiley & Sons, Inc</publisher><subject>Age groups ; Calories ; Cardiac arrhythmia ; Case reports ; Convulsions & seizures ; Diet ; Diet, Ketogenic - adverse effects ; Electroencephalography ; Epilepsy ; Epilepsy - drug therapy ; Humans ; Hypoglycemia ; Infant ; Infant, Newborn ; ketogenic diet ; Ketone Bodies - therapeutic use ; Ketosis ; neonate ; newborn ; Nutrition research ; Patients ; premature ; preterm ; Short ; Short s ; Treatment Outcome ; Twins</subject><ispartof>Epilepsia open, 2023-03, Vol.8 (1), p.200-204</ispartof><rights>2022 The Authors. published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.</rights><rights>2022 The Authors. Epilepsia Open published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.</rights><rights>2023. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5813-b991cda40f3ad1a48c9461c6251881564e39b81ef1c7e56e67daab008c6bb8ae3</citedby><cites>FETCH-LOGICAL-c5813-b991cda40f3ad1a48c9461c6251881564e39b81ef1c7e56e67daab008c6bb8ae3</cites><orcidid>0000-0002-1201-0586 ; 0000-0001-5499-3835</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2781016420/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2781016420?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,11541,25731,27901,27902,36989,36990,44566,46027,46451,53766,53768,74869</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36398475$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Phitsanuwong, Chalongchai</creatorcontrib><creatorcontrib>Kim, Jeong‐A</creatorcontrib><creatorcontrib>Schimpf, Stephanie</creatorcontrib><creatorcontrib>Nordli, Douglas R.</creatorcontrib><title>Experience with the ketogenic diet in premature neonates</title><title>Epilepsia open</title><addtitle>Epilepsia Open</addtitle><description>The ketogenic diet is a time‐tested, potent, nonpharmacological treatment of epilepsy. However, the use of the ketogenic diet in premature neonates with epilepsy has not been previously reported. We share our experience with the use of ketogenic diet therapy in two premature neonates. Two identical twin premature neonates with SCN2A‐related developmental and epileptic encephalopathy, whose seizures were refractory to multiple anti‐seizure medications, were started on the classic ketogenic diet at the conceptual age of 35 weeks. Ketosis was achieved and maintained (range 2‐5 mmol/L of serum beta‐hydroxybutyrate level). Seizure frequency was significantly reduced (>90% reduction in both patients), and some anti‐seizure medications were able to be discontinued. Initial transient weight loss and one episode of asymptomatic hypoglycemia were observed and corrected. The ketogenic diet was found to be a safe, well‐tolerated, and effective treatment for seizures in two premature neonates. The side effects are tolerable and correctable. The ketogenic diet, therefore, is a treatment option for refractory seizures in this age group, when administered under expert guidance.</description><subject>Age groups</subject><subject>Calories</subject><subject>Cardiac arrhythmia</subject><subject>Case reports</subject><subject>Convulsions & seizures</subject><subject>Diet</subject><subject>Diet, Ketogenic - adverse effects</subject><subject>Electroencephalography</subject><subject>Epilepsy</subject><subject>Epilepsy - drug therapy</subject><subject>Humans</subject><subject>Hypoglycemia</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>ketogenic diet</subject><subject>Ketone Bodies - therapeutic use</subject><subject>Ketosis</subject><subject>neonate</subject><subject>newborn</subject><subject>Nutrition research</subject><subject>Patients</subject><subject>premature</subject><subject>preterm</subject><subject>Short</subject><subject>Short s</subject><subject>Treatment Outcome</subject><subject>Twins</subject><issn>2470-9239</issn><issn>2470-9239</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kU1v1DAQhi0EolXphR-AInFBSFs8seOPCxKqFlipEhzgbNnOZNdLNg6OQ-m_x9uUquXAyZbn8TOjeQl5CfQCKK3f4Rj4BdRCsifktOaSrnTN9NMH9xNyPk17SinoGkDQ5-SECaYVl80pUevfI6aAg8fqOuRdlXdY_cActzgEX7UBcxWGakx4sHlOWA0YB5txekGedbaf8PzuPCPfP66_XX5eXX35tLn8cLXyjQK2clqDby2nHbMtWK685gK8qBtQChrBkWmnADvwEhuBQrbWOkqVF84pi-yMbBZvG-3ejCkcbLox0QZz-xDT1tiUg-_RaPTle9txh5ZraZ0Dd2zUWOkVQltc7xfXOLsDth6HnGz_SPq4MoSd2cZfRmspJVdF8OZOkOLPGadsDmHy2Pe2rGWeTC2ZAs2VpAV9_Q-6j3MayqoKpYCC4PWRertQPsVpStjdDwPUHPM1x3zNbb4FfvVw_Hv0b5oFgAW4Dj3e_Edl1l83fJH-AYWTr4s</recordid><startdate>202303</startdate><enddate>202303</enddate><creator>Phitsanuwong, Chalongchai</creator><creator>Kim, Jeong‐A</creator><creator>Schimpf, Stephanie</creator><creator>Nordli, Douglas R.</creator><general>John Wiley & Sons, Inc</general><general>John Wiley and Sons Inc</general><general>Wiley</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-1201-0586</orcidid><orcidid>https://orcid.org/0000-0001-5499-3835</orcidid></search><sort><creationdate>202303</creationdate><title>Experience with the ketogenic diet in premature neonates</title><author>Phitsanuwong, Chalongchai ; Kim, Jeong‐A ; Schimpf, Stephanie ; Nordli, Douglas R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5813-b991cda40f3ad1a48c9461c6251881564e39b81ef1c7e56e67daab008c6bb8ae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Age groups</topic><topic>Calories</topic><topic>Cardiac arrhythmia</topic><topic>Case reports</topic><topic>Convulsions & seizures</topic><topic>Diet</topic><topic>Diet, Ketogenic - adverse effects</topic><topic>Electroencephalography</topic><topic>Epilepsy</topic><topic>Epilepsy - drug therapy</topic><topic>Humans</topic><topic>Hypoglycemia</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>ketogenic diet</topic><topic>Ketone Bodies - therapeutic use</topic><topic>Ketosis</topic><topic>neonate</topic><topic>newborn</topic><topic>Nutrition research</topic><topic>Patients</topic><topic>premature</topic><topic>preterm</topic><topic>Short</topic><topic>Short s</topic><topic>Treatment Outcome</topic><topic>Twins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Phitsanuwong, Chalongchai</creatorcontrib><creatorcontrib>Kim, Jeong‐A</creatorcontrib><creatorcontrib>Schimpf, Stephanie</creatorcontrib><creatorcontrib>Nordli, Douglas R.</creatorcontrib><collection>Wiley Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Epilepsia open</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Phitsanuwong, Chalongchai</au><au>Kim, Jeong‐A</au><au>Schimpf, Stephanie</au><au>Nordli, Douglas R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Experience with the ketogenic diet in premature neonates</atitle><jtitle>Epilepsia open</jtitle><addtitle>Epilepsia Open</addtitle><date>2023-03</date><risdate>2023</risdate><volume>8</volume><issue>1</issue><spage>200</spage><epage>204</epage><pages>200-204</pages><issn>2470-9239</issn><eissn>2470-9239</eissn><abstract>The ketogenic diet is a time‐tested, potent, nonpharmacological treatment of epilepsy. However, the use of the ketogenic diet in premature neonates with epilepsy has not been previously reported. We share our experience with the use of ketogenic diet therapy in two premature neonates. Two identical twin premature neonates with SCN2A‐related developmental and epileptic encephalopathy, whose seizures were refractory to multiple anti‐seizure medications, were started on the classic ketogenic diet at the conceptual age of 35 weeks. Ketosis was achieved and maintained (range 2‐5 mmol/L of serum beta‐hydroxybutyrate level). Seizure frequency was significantly reduced (>90% reduction in both patients), and some anti‐seizure medications were able to be discontinued. Initial transient weight loss and one episode of asymptomatic hypoglycemia were observed and corrected. The ketogenic diet was found to be a safe, well‐tolerated, and effective treatment for seizures in two premature neonates. The side effects are tolerable and correctable. The ketogenic diet, therefore, is a treatment option for refractory seizures in this age group, when administered under expert guidance.</abstract><cop>United States</cop><pub>John Wiley & Sons, Inc</pub><pmid>36398475</pmid><doi>10.1002/epi4.12673</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0002-1201-0586</orcidid><orcidid>https://orcid.org/0000-0001-5499-3835</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2470-9239 |
ispartof | Epilepsia open, 2023-03, Vol.8 (1), p.200-204 |
issn | 2470-9239 2470-9239 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_9ec67ddf4bea497abb1b62515a7c8e1d |
source | Open Access: PubMed Central; Publicly Available Content Database; Wiley Open Access |
subjects | Age groups Calories Cardiac arrhythmia Case reports Convulsions & seizures Diet Diet, Ketogenic - adverse effects Electroencephalography Epilepsy Epilepsy - drug therapy Humans Hypoglycemia Infant Infant, Newborn ketogenic diet Ketone Bodies - therapeutic use Ketosis neonate newborn Nutrition research Patients premature preterm Short Short s Treatment Outcome Twins |
title | Experience with the ketogenic diet in premature neonates |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T14%3A58%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Experience%20with%20the%20ketogenic%20diet%20in%20premature%20neonates&rft.jtitle=Epilepsia%20open&rft.au=Phitsanuwong,%20Chalongchai&rft.date=2023-03&rft.volume=8&rft.issue=1&rft.spage=200&rft.epage=204&rft.pages=200-204&rft.issn=2470-9239&rft.eissn=2470-9239&rft_id=info:doi/10.1002/epi4.12673&rft_dat=%3Cproquest_doaj_%3E2781016420%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5813-b991cda40f3ad1a48c9461c6251881564e39b81ef1c7e56e67daab008c6bb8ae3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2781016420&rft_id=info:pmid/36398475&rfr_iscdi=true |